2025
Multimodality imaging review of retroperitoneal fibrosis
Czerniak S, Mathur M. Multimodality imaging review of retroperitoneal fibrosis. Abdominal Radiology 2025, 1-19. PMID: 40035807, DOI: 10.1007/s00261-025-04847-6.Peer-Reviewed Original ResearchRetroperitoneal fibrosisSecondary causesEvaluation of retroperitoneal fibrosisAssociated with autoimmune diseasesNonspecific clinical presentationIgG4 related diseasePotential diagnostic pitfallsDiffusion weighted imagingMagnetic resonance imagingAdvanced imaging techniquesPET/CT imagingClinical presentationMultimodality imaging reviewVenous stenosisClinical featuresDiagnostic pitfallsFibroinflammatory diseaseImaging findingsAutoimmune diseasesImaging reviewInflammatory disordersIdiopathic diseaseTreatment approachesImaging appearanceImaging modalitiesEndovascular Embolization versus Observation of Congenital Renal Arteriovenous Malformations: A Retrospective Study
Hufnagle J, Fish A, Schlachter T. Endovascular Embolization versus Observation of Congenital Renal Arteriovenous Malformations: A Retrospective Study. Journal Of Vascular And Interventional Radiology 2025, 36: 988-993.e1. PMID: 39938714, DOI: 10.1016/j.jvir.2025.02.001.Peer-Reviewed Original ResearchCongenital renal arteriovenous malformationRenal arteriovenous malformationType I AVMArteriovenous malformationsEndovascular embolizationAdverse eventsImaging review of patientsReview of patientsArteriovenous malformation ruptureFollow-up dataYakes classificationTransarterial embolizationEmbolization groupPresenting symptomsPatient demographicsRetrospective studyProcedural imagingImaging reviewEmbolizationPatientsObservation groupMalformationsComplicationsVessel sizeNephrectomy
2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy
Hoppe B, McCarten K, Pei Q, Kessel S, Alazraki A, Mhlanga J, Lai H, Eutsler E, Hodgson D, Roberts K, Charpentier A, Keller F, Voss S, Wu Y, Cho S, Kelly K, Castellino S. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2023, 116: 1025-1030. PMID: 36868525, PMCID: PMC10363760, DOI: 10.1016/j.ijrobp.2023.02.020.Peer-Reviewed Original ResearchConceptsCentral reviewDeauville scoreCentral imaging reviewRadiation therapyResponse assessmentHodgkin's lymphomaImaging reviewInstitutional reviewFluorodeoxyglucose positron emission tomography/High-risk Hodgkin lymphomaPositron emission tomography responseConcordance rateEmission tomography/Real-time central reviewCohen κ statisticAreas of diseaseSystemic therapyTreating institutionPediatric patientsLymphoma trialsTomography responseTomography/Treatment allocationClinical trialsPatientsTelemedicine: An Effective Tool for Patient-Physician Communication.
Sabetian P, Ouyang V, Fox J, Jimenez A, Ankem H, Saks B, Maldonado D, Lall A, Domb B. Telemedicine: An Effective Tool for Patient-Physician Communication. Orthopedics 2023, 46: e173-e178. PMID: 36623281, DOI: 10.3928/01477447-20230104-07.Peer-Reviewed Original ResearchConceptsTelemedicine visitsPatient-physician communicationPresurgical groupConservative treatmentSurgical treatmentPerson visitsFurther medical assessmentSurgical indicationsPostsurgical groupImaging reviewMean ageTelemedicine appointmentsHip clinicSurgery dateHip proceduresPatientsMedical assessmentVisitsMonthsCOVID-19 pandemicTreatmentGroupIndicationsClinicCohort
2022
LGG-52. Volumetry-based response characterization of recurrent pediatric low-grade gliomas in PNOC clinical Neuro-oncology trials
von Reppert M, Lin M, Bousabarah K, Familiar A, Velasco R, Waanders A, Vossough A, Haddock A, Nicolaides T, Swanson K, Kazerooni A, Kline C, Nabavizadeh A, Haas-Kogan D, Prados M, Rubin J, Mueller S, Aboian M. LGG-52. Volumetry-based response characterization of recurrent pediatric low-grade gliomas in PNOC clinical Neuro-oncology trials. Neuro-Oncology 2022, 24: i100-i100. PMCID: PMC9165161, DOI: 10.1093/neuonc/noac079.364.Peer-Reviewed Original ResearchPediatric low-grade gliomasClinical trialsLow-grade gliomasRANO criteriaResponse assessmentNeuro-oncology trialsSingle-agent everolimusTreatment response analysisCentral imaging reviewInter-reader agreementClinical outcomesTumor sizeImaging reviewCystic componentTreatment responseTumor volumeTrue tumor volumeNovel treatmentsVolumetric assessmentTrial outcomesVolumetric measuresEntire tumorOverall discordanceNeuroradiology practiceTrials
2021
Longitudinal imaging history in early identification of intimate partner violence
Park H, Gujrathi R, Gosangi B, Thomas R, Cai T, Chen I, Bay C, Hassan N, Boland G, Kohane I, Seltzer S, Rexrode K, Khurana B. Longitudinal imaging history in early identification of intimate partner violence. European Radiology 2021, 32: 2824-2836. PMID: 34797386, DOI: 10.1007/s00330-021-08362-2.Peer-Reviewed Original ResearchConceptsSelf-reported dateIPV-related injuriesGroup 1Neurological injuryMusculoskeletal injuriesGroup 2Early identificationGroup 2 patientsIntimate partner violencePhysical abuseTypes of abuseNeurologic injuryHigh suspicionCommon injuriesResultsA totalImaging reviewPartner violenceInjuryStudy datesLikelihood of IPVCommon typeRadiologistsPatientsSuspicionIPVNational Trends in Telestroke Utilization in a US Commercial Platform Prior to the COVID-19 Pandemic
Zachrison KS, Sharma R, Wang Y, Mehrotra A, Schwamm LH. National Trends in Telestroke Utilization in a US Commercial Platform Prior to the COVID-19 Pandemic. Journal Of Stroke And Cerebrovascular Diseases 2021, 30: 106035. PMID: 34419836, PMCID: PMC8494566, DOI: 10.1016/j.jstrokecerebrovasdis.2021.106035.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCOVID-19Databases, FactualFemaleFibrinolytic AgentsHumansMaleMiddle AgedPractice Patterns, Physicians'Quality ImprovementQuality Indicators, Health CareRemote ConsultationStrokeThrombolytic TherapyTime FactorsTime-to-TreatmentTissue Plasminogen ActivatorTreatment OutcomeUnited StatesConceptsIschemic stroke patientsTelestroke consultationAlteplase deliveryStroke patientsNumber of patientsNumber of consultsCOVID-19 public health emergencyPublic health emergencyAlteplase useMedian doorNeedle timeStroke severityED arrivalEmergency departmentImaging reviewHospital characteristicsTelestroke networkCT scanHospital participationSpoke sitesProvider groupsPatientsHospital sizeStudy periodHealth emergencyA prospective phase 2/3 study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging.
Durack J, Alva A, Preston M, Pouliot F, Saperstein L, Carroll P, Pienta K, Rowe S, Patnaik A, Probst S, Stambler N, Jensen J, Wong V, Siegel B, Morris M. A prospective phase 2/3 study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging. Journal Of Clinical Oncology 2021, 39: e17003-e17003. DOI: 10.1200/jco.2021.39.15_suppl.e17003.Peer-Reviewed Original ResearchF-DCFPyL PET/CTProstate cancerF-DCFPyLPositron emission tomographyConventional imagingM1 diseaseBone scintigraphyStaging of PCaHigh-risk prostate cancerWhole-body bone scintigraphyM1 stage diseasePhase 2/3 studyCT detection rateMajority of patientsPET/CTLocoregional diseaseRadiologic evidenceStage diseaseLocal recurrenceMetastatic diseasePelvic LNSingle doseTNM stagingImaging reviewLesion countsA prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging.
Durack J, Alva A, Preston M, Pouliot F, Saperstein L, Carroll P, Pienta K, Rowe S, Patnaik A, Probst S, Stambler N, Jensen J, Wong V, Siegel B, Morris M. A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging. Journal Of Clinical Oncology 2021, 39: 32-32. DOI: 10.1200/jco.2021.39.6_suppl.32.Peer-Reviewed Original ResearchF-DCFPyL PET/CTProstate cancerF-DCFPyLPositron emission tomographyConventional imagingM1 diseaseBone scintigraphyPhase II/III studyStaging of PCaHigh-risk prostate cancerWhole-body bone scintigraphyM1 stage diseaseCT detection rateMajority of patientsPET/CTLocoregional diseaseRadiologic evidenceIII studyStage diseaseLocal recurrenceMetastatic diseasePelvic LNSingle doseTNM stagingImaging review
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply